Fusion Pharmaceuticals Inc. Deferred Revenue Recognized
Fusion Pharmaceuticals Inc. reported Deferred Revenue Recognized of $2.00 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-20.
Discontinued › Income Statement › Other Income
us-gaap:ContractWithCustomerLiabilityRevenueRecognized · last filed 2024-03-20
- Fusion Pharmaceuticals Inc. contract with customer, liability, revenue recognized for the quarter ending 2023-09-30 was $2.00M, a 1462.50% increase year-over-year.
- Fusion Pharmaceuticals Inc. contract with customer, liability, revenue recognized for the quarter ending 2022-09-30 was $128.00K, a 12.33% decline year-over-year.
- Fusion Pharmaceuticals Inc. contract with customer, liability, revenue recognized for the quarter ending 2022-06-30 was $393.00K, a 1.75% decline year-over-year.
- Fusion Pharmaceuticals Inc. contract with customer, liability, revenue recognized for the quarter ending 2022-03-31 was $438.00K.
- Fusion Pharmaceuticals Inc. contract with customer, liability, revenue recognized for fiscal 2023 was $2.00M, a 92.68% increase from fiscal 2022.
- Fusion Pharmaceuticals Inc. contract with customer, liability, revenue recognized for fiscal 2022 was $1.04M, a 7.90% increase from fiscal 2021.
- Fusion Pharmaceuticals Inc. contract with customer, liability, revenue recognized for fiscal 2021 was $962.00K.
| Period end | Contract with Customer, Liability, Revenue Recognized 3 month | Contract with Customer, Liability, Revenue Recognized 6 month | Contract with Customer, Liability, Revenue Recognized 9 month | Contract with Customer, Liability, Revenue Recognized 12 month |
|---|---|---|---|---|
| 2023-12-31 | $2.00M 10-K · filed 2024-03-20 | |||
| 2023-09-30 | $2.00M 10-Q · filed 2023-11-07 | $2.00M 10-Q · filed 2023-11-07 | ||
| 2022-12-31 | $1.04M 10-K · filed 2024-03-20 | |||
| 2022-09-30 | $128.00K 10-Q · filed 2023-11-07 | $959.00K 10-Q · filed 2023-11-07 | ||
| 2022-06-30 | $393.00K 10-Q · filed 2023-08-08 | $831.00K 10-Q · filed 2023-08-08 | ||
| 2022-03-31 | $438.00K 10-Q · filed 2023-05-11 | |||
| 2021-12-31 | $962.00K 10-K · filed 2023-03-16 | |||
| 2021-09-30 | $146.00K 10-Q · filed 2022-11-08 | $546.00K 10-Q · filed 2022-11-08 | ||
| 2021-06-30 | $400.00K 10-Q · filed 2022-08-09 | $400.00K 10-Q · filed 2022-08-09 |